← Back to headlines
BioNTech outlines $1B buyback, targets €500M annual savings, reaffirms 2026 revenue
BioNTech has outlined plans for a share buyback program of up to $1 billion and aims for approximately €500 million in annual savings. The company also reaffirmed its 2026 revenue target of €2.0B-€2.3B.
5 May, 19:22 — 5 May, 19:22
Sources
Showing 1 of 1 sources
